Maprotiline versus fluvoxamine: Comparison between their actions on hypothalamic-pituitary-thyroid axis;Maprotiline versus fluvoxamine: Comparaison entre leurs actions sur l'axe hypothalamo-hypophyso-thyroidien

Encephale

Volumn 23, Issue 1, 1997, Pages 48-55

  De Mendonca Lima C A ^a   Vandel, S ^b   Bonin, B ^b   Bechtel, P ^b   Carron, R ^c  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY HOSPITAL OF BESANÇON   (France)

^c Hopital Psychiatrique de Malevoz   (Switzerland)

Author keywords

depression; fluvoxamine; maprotiline; thyroid hormones

Indexed keywords

FLUVOXAMINE; LIOTHYRONINE; MAPROTILINE; PROTIRELIN; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DYSTHYMIA; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM; MALE; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DEPRESSIVE DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DYSTHYMIC DISORDER; FEMALE; FLUVOXAMINE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MAPROTILINE; MIDDLE AGED; THYROID GLAND; THYROTROPIN; THYROTROPIN-RELEASING HORMONE; THYROXINE; TRIIODOTHYRONINE;

EID: 0030994720     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. AMERICAN PSYCHIATRIC ASSOCIATION. DSM III-R. Manuel diagnostique et statistique des troubles mentaux. Paris : Masson, 1992, p. 624.
2. ASBERG M, MONTGOMERY SA, PERRIS C, SCHALLING D, SEDVALL G. A comprehensive psychopathological rating scale. Acta Psychiatr Scand 1978 (suppl 271) : 5-27.
3. BENFIELD P, WARD A. Fluvoxamine : a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressed illness. Drugs 1986 ; 32 (4) : 313-34.
4. BRADY KT, ANTON RF. The thyroid axis and desimipramine treatment in depression. Biol Psychiatry 1989 ; 25 (6) : 703-9.
5. CLASSEN V, DAVIES JE, HERTING G, PLACHETA P. Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibition. Br J Pharmacol 1977 ; 60(4) : 505-16.
6. FAVA M, ROSENBAUM JF, McLAYGHLIN R, POLLACK MH, COHEN LS, JONES L, PIL L. Neuroendocrine effects of S-adenosyl-L-methionine, a novel putative antidepressant. J Psychiatr Res 1990 ; 24(2) : 177-84.
7. JOFFE RT, SINGER W. Effect of phenelzine on thyroid function in depressed patients. Biol Psychiatry 1987 ; 22 (8) : 1033-4.
8. JOFFE RT, SINGER W. Effect of tricyclic antidepressants on thyroid hormone levels in depressed patients. Pharmacopsychiatry 1990 ; 23 (2) : 67-9.
9. KIRKEGAARD C. The thyrotropin response to thyrotropin-releasing hormone in endogenous depression. Psychoneuroendocrinology 1981 ; 6(2) : 189-212.
10. KIRKEGAARD C, FABER J. Altered serum levels of thyroxine, triiodothyronines and diiodothyronines in endogenous depression. Acta Endocrinol 1981 ; 96 (2) : 199-207.
11. KIRKEGAARD C, FABER J. Influence of free-thyroid hormone levels on the TSH response to TRH in endogenous depression. Psychoneuroendocrinology 1986 ; 11 (4) : 491-7.
12. KIRKEGAARD C, SMITH E. Continuation therapy in endogenous depression controlled by changes in the TRH stimulation test. Psychol Med 1978 ; 8 (3) : 501-3.
13. KIRKEGAARD C, NORLEM N, LAURIDSEN UB, BJORUM N. Pronostic value of thyrotropin releasing hormone stimulation test in endogenous depression. Acta Psychiatr Scand 1975 ; 52 (3) : 170-7.
14. KIRKEGAARD C, NORLEM N, LAURIDSEN UB, BJORUM N, CHRISTIANSEN C. Protirelin stimulation test and thyroid function during treatment of depression. Arch Gen Psychiatry 1975 ; 32 (9) : 1115-9.
15. KIRKEGAARD C, BJORUM N, COHN D, FABER J, LAURIDSEN UB, NERUP J. Studies on the influence of biogenic amines and psychoactive drugs on the prognostic value of the TRH stimulation test in endogenous depression. Psychoneuroendocrinology 1977 ; 2 (2) : 131-6.
16. KIRKEGAARD C, BJORUM N, COHN D, LAURIDSEN UB. Thyrotropin-releasing hormone (TRH) stimulation test in manic-depressive illness. Arch Gen Psychiatry 1977 ; 35 (8) : 1017-21.
17. KIRKEGAARD C. The thyrotropin response to thyrotropin-releasing hormone in endogenous depression. Psychoneuroendocrinology 1981 ; 6 (2) : 189-212.
18. KROG-MEYER I, KIRKEGAARD C, KJINE B, LUMHOLTZ B, SMITH E, LYKKE-OLENSEN L, BJORUM N. Effect of amitriptyline on the thyrotropin responses to thyrotropin-releasing hormone in endogenous depression. Psychiatry Res 1985 ; 15 (2) : 145-51.
19. KROG-MEYER I, KIRKEGAARD C, KJINE B, LUMHOLTZ B, SMITH E, LYKKE-OLENSEN L, BJORUM N. Prediction of relapse with the TRH test and prophylatic amitriptyline in 39 patients with endogenous depression. Am J Psychiatry 1984 ; 141 (8) : 945-8.
20. LANGER G, RESCH F, ASCHAUER H, KESHAVAN MS, KOINIG G, SCHONBECK G, DITTRICH R. TSH-response patterns to TRH stimulation may indicate therapeutic mechanisms of antidepressants and neuroleptic drugs. Neuropsychobiology 1984 ; 11 (4) : 213-5.
21. LANGER G, ASCHAUER H, KOINIG G, RESCH F, SCHONBECKG. The TSH-response to TRH : a possible predictor of outcome to antidepressant and neuroleptic treatment. Prog Neuropsychopharmacol Biol Psychiatry 1983 ; 7 (2-3) : 335-42.
22. LEICHTER SB, KIRSTEN L, MARTIN ND. Thyroid function and growth hormone secretion in amitriptyline-treated depression. Am J Psychiatry 1977 ; 134 (11) : 1270-2.
23. LINNOILA M, LEPPALUOTO S, SEPPALA T, RANTA T. Serum gonadotropin and TSH levels after tricyclic antidepressants in healthy males. Acta Pharmacol Toxicol 1977 ; 41 (3) : 285-8.
24. MAITRE L, STAEHELIN M, BEIN HJ. Blockade of noradrenalin uptake by 34 276 - Ba, a new antidepressant drug. Biochem Pharmacol 1971 ; 20 (9) : 2169-86.
25. NORDGREN L, von SCHEELE C. Nortriptyline and pituitary-thyroid function in affective disorder. Pharmacopsychiatria 1981 ; 14 (2) : 61-5.
26. RUHMANN S, KASPER S, HAWELLER B, BIERSACK HJ, MOLLER HJ. Fluoxetine treatment and thyroid hormones in seasonal affective disorders. Europ Neuropsychopharmacol 1993 ; 3 (3) : 336-7.
27. SCHLIENGER JL, KAPFER MTh, SINGER L, STEPHAN F. The action of clomipramine on thyroid function. Horm Metab Res 1980 ; 12 (10) : 481-2.
28. WIDERLOV E, WIDE L, SJOSTROM R. Effects of tricyclic antidepressants on human plasma levels of TSH, GH and prolactin. Acta Psychiatr Scand 1978 ; 56 (5) : 449-56.